This review article aims at discussing the potential of therapeutic GLP-1 receptor agonists in alleviating depressive symptoms in the context of modern theories surrounding the pathogenesis of this disease and explores their influence on cognitive processes, neurotransmission, modulation of neuroinflammatory processes, effects on HPA axis activity, brain energy balance, and the functioning of the gut-brain axis
American Journal of Clinical Nutrition, 101(6), pp.13201329
Orders under the free-shipping threshold incur a $9.95 shipping fee, which is the highest base shipping cost in this guide
Author contributions The following authors: KT, RC, AY, JO, TN, KS, CV, MS, and ET were involved in both subject recruitment and conducting the assays